Your session is about to expire
← Back to Search
HCV care provided by hospitalist during acute psychiatric admission for Hepatitis C
Study Summary
This trial will test whether treating HCV during a psychiatric admission, rather than referring to specialty care, is feasible and beneficial.
- Hepatitis C
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What risks may be associated with hepatitis C care administered by hospitalists during an acute psychiatric visit?
"HCV care provided by hospitalists in the setting of acute psychiatric admissions has been deemed safe and is thus assigned a score of 3 on our scale. This is due to this intervention having achieved Phase 4 trial status, indicating its approval for use as a medical treatment."
Are there opportunities for new participants in this trial?
"Affirmative. The clinical trial's webpage on clinicaltrials.gov corroborates that enrolment is still ongoing, with the experiment first listed on April 19th 2022 and last updated a few days later, on April 28th of the same year. Only 54 individuals are required to be recruited at 1 specific medical site."
Does the admission criteria for this trial include individuals aged sixty and over?
"This medical experiment is open to potential participants of legal age, with the upper limit set at 80 years old."
To what extent is participation in this experiment widespread?
"Affirmative. Clinicaltrials.gov hosts information that clearly demonstrates this clinical trial is actively recruiting patients, having been posted on April 19th and edited most recently on April 28th 2022. Only 54 participants are necessary at a single site to fulfil the requirements of this medical study."
Could I be accepted as a participant for this experiment?
"To be considered for this study, candidates must possess hepatitis c and be in the age range of 18 - 80. A total of 54 individuals are needed to participate."
Share this study with friends
Copy Link
Messenger